Home Health News Brainomix, Nanoflex Robotics companion to create AI robotics platform for stroke

Brainomix, Nanoflex Robotics companion to create AI robotics platform for stroke

0
Brainomix, Nanoflex Robotics companion to create AI robotics platform for stroke

[ad_1]

British medtech firm Brainomix and Switzerland-based distant robotic surgical firm Nanoflex Robotics introduced the receipt of £400,000 ($420,418) and CHF 400,000 ($443,700), respectively, to co-develop an AI-assisted magnetic navigation system for stroke-related robotic surgical instruments.

Innovate UK, the innovation company in the UK, and Innosuisse, Switzerland’s Innovation Company, awarded the funds. 

Brainomix, spun out of the College of Oxford, creates AI-enabled software program to help in remedy decision-making for stroke, most cancers and lung fibrosis.

Nanoflex is a medical robotics firm specializing in the remedy of ischemic stroke. The corporate developed a delicate robotics system that inserts guidewires and catheters into the mind. It says its tech can simplify and shorten process time whereas decreasing dangers related to assessing the mind for interventional stroke remedy. 

By way of the partnership, beginning in 2024, the businesses will mix their applied sciences to create an AI-assisted navigation instrument for gadgets, corresponding to catheters, as they transfer by the vascular system.

“The venture goals to leverage the facility of synthetic intelligence to reinforce Nanoflex Robotics’ cutting-edge magnetic robotic navigation system to be the primary system worldwide to allow distant thrombectomy, thus reworking stroke remedy choices and serving to enhance outcomes for sufferers,” Dr. George Harston, chief medical and innovation officer at Brainomix, mentioned in an announcement.

THE LARGER TREND

Earlier this 12 months, Brainomix obtained FDA clearance for its AI-enabled stroke software program Brainomix 360 e-ASPECTS, utilized in stroke sufferers to measure the extent of early ischemic adjustments or a discount or restriction of blood circulate within the mind.

In 2021, the corporate closed a £16 million ($16.8 million) Series B funding round.

Earlier this month, Nanoflex Robotics introduced it scored a second grant from the Swiss Innovation Company, bringing its whole grant funding this 12 months to CHF 2.9 million ($3.2 million)

In February, the corporate additionally obtained $12 million in funding in a spherical led by Ascend Capital Companions with participation from Kinled Holding Ltd and Mountain Labs AG.

Different corporations within the robotics healthcare area are California-based Mendaera, which garnered $24 million in Series A funding in August, and Diligent Robotics, which scored $25 million in funding final month to broaden the attain of its ‘socially clever service robots.’  

[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here